Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe (2012)
- Authors:
- USP affiliated authors: DOREA, EGIDIO LIMA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: HU; FCF
- Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; INFLAMAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 48, suppl. 1, p. 23 res.FCF002 , 2012
- Conference titles: Pharmaceutical Science and Technology Meeting
-
ABNT
GUIMARAES, Elizandra et al. Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Hospital Universitário, Universidade de São Paulo. . Acesso em: 23 abr. 2024. , 2012 -
APA
Guimaraes, E., Cerda, A., Dorea, E., Hirata, M. H., & Hirata, R. D. C. (2012). Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Hospital Universitário, Universidade de São Paulo. -
NLM
Guimaraes E, Cerda A, Dorea E, Hirata MH, Hirata RDC. Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 23 res.FCF002 .[citado 2024 abr. 23 ] -
Vancouver
Guimaraes E, Cerda A, Dorea E, Hirata MH, Hirata RDC. Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 23 res.FCF002 .[citado 2024 abr. 23 ] - Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
